Characterizing Malignant Tumors Using Ultrasound Doppler Imaging

NCT ID: NCT03598335

Last Updated: 2018-07-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-07-31

Study Completion Date

2019-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to determine whether Ultrasound Doppler imaging can identify malignant tumors at a very early stage.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malignant Tumor of Women's Reproductive System

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women with malignant tumor

Women with malignant tumor in reproductive system

Ultrasound

Intervention Type DEVICE

Ultrasound imaging of women arriving at clinic for routine care

Women with benign tumor

Women with benign tumor in reproductive system

Ultrasound

Intervention Type DEVICE

Ultrasound imaging of women arriving at clinic for routine care

Women with no observed tumor

Women with no observed tumor in reproductive system

Ultrasound

Intervention Type DEVICE

Ultrasound imaging of women arriving at clinic for routine care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound

Ultrasound imaging of women arriving at clinic for routine care

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women presenting for routine abdominal/vaginal ultrasound

Exclusion Criteria

* Pregnant women
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hillel Yaffe Medical Center

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alon Shrim, MD

Role: PRINCIPAL_INVESTIGATOR

Hillel Yaffe Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hille Yaffe Medical Center

Hadera, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Genya Peisahov, BSc

Role: CONTACT

972-54-8886349

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Genya Peisahov, BSc

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HYMC-0096-17

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Utility of ICG in Benign Bone Tumors
NCT05075889 COMPLETED EARLY_PHASE1